Point-of-care biosensors have been crucial in handling the COVID-19 pandemic, which has caused the market to more than double since 2019. In this report IDTechEx explores the drivers of the market's growth, key technologies enabling point-of-care testing, assesses emerging technologies bringing patient diagnosis ever closer to the point-of-care, and the opportunities and threats that these trends present.